News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kennedy Eugene P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/28/2023 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $1.78, valued at
$97.9k
|
|
| 09/02/2022 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.29, valued at
$193.5k
|
|
| 09/02/2022 |
3
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 3 on Galera Therapeutics, Inc. |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2020 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 9,000 shares
@ $0
Granted 45,000 options to buy
@ $7.87, valued at
$354.2k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2019 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on NEWLINK GENETICS CORP|
Txns:
| Granted 185,000 options to buy
@ $1.8, valued at
$333k
|
|
| 02/14/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on NEWLINK GENETICS CORP|
Txns:
| Paid exercise price by delivering 376 shares
@ $1.55, valued at
$582.8 |
|
| 03/13/2018 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on NEWLINK GENETICS CORP|
Txns:
| Granted 110,000 options to buy
@ $7.85, valued at
$863.5k
|
|
| 01/23/2018 |
4
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 4 on NEWLINK GENETICS CORP|
Txns:
| Paid exercise price by delivering 85 shares
@ $8.62, valued at
$732.7 |
|
| 01/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2018 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 11/22/2017 |
3
| Kennedy Eugene P. (Chief Medical Officer) has filed a Form 3 on NEWLINK GENETICS CORP |
|
|